December 2021

Contents

Editorial

• HTB: no. 12 – plus HIV and COVID-19 (Dec 2021)

Conference reports

• 18th International European AIDS Conference (EACS 2021)

• EACS case study: how to diagnose HIV on PrEP – stopping PrEP or intensify to ART?

• European AIDS Clinical Society honours Simon Collins for longstanding contribution to the field of HIV

Antiretrovirals

• Selected islatravir studies stop enrolment: further complications with important investigational drugs

• FDA further limit use of islatravir in ongoing studies

Coinfections and complications

• The importance of confirming screening test results for diabetes and hypertension

• ECG abnormalities reported by 44% of people older than 40 on ART: results from REPRIEVE study

• Rare cases of PML diagnosed at CD4 >200 with undetectable viral load

HIV prevention and transmission

• US FDA approves long-acting cabotegravir injections for PrEP: price set at $22,000 a year

• 56 Dean Street reports M184V common with recent low adherence to PrEP and seven transmissions with good adherence

Cure-related research

• Reducing the risk of COVID-19 in research that involves interrupting ART

• IAS strategy for an HIV cure (2021): easy-to-read Q&A

Book and film reviews

• Right to Try: activists challenge a flawed film about a potential HIV cure

COVID-19: HIV and COVID-19 coinfection

• New BHIVA statements on HIV and COVID-19 (December 2021)

COVID-19: vaccine research

• Myocarditis and pericarditis after COVID-19 vaccines

COVID-19: investigational drugs

• WHO advises against use of convalescent plasma for COVID-19

PDFs

• HTB: no. 12 – plus HIV and COVID-19 (20 December 2021)